

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.01585112 |
| 2 | negative regulation of cell killing (GO:0031342) | 6.01585112 |
| 3 | positive thymic T cell selection (GO:0045059) | 4.59542457 |
| 4 | positive regulation of B cell differentiation (GO:0045579) | 4.54739380 |
| 5 | negative thymic T cell selection (GO:0045060) | 4.34687483 |
| 6 | negative T cell selection (GO:0043383) | 4.22328288 |
| 7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.18903478 |
| 8 | regulation of gamma-delta T cell activation (GO:0046643) | 4.16008607 |
| 9 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.15360696 |
| 10 | regulation of B cell differentiation (GO:0045577) | 4.07114540 |
| 11 | detection of bacterium (GO:0016045) | 3.95368789 |
| 12 | regulation of mast cell degranulation (GO:0043304) | 3.93807959 |
| 13 | leukocyte aggregation (GO:0070486) | 3.93674845 |
| 14 | response to interleukin-15 (GO:0070672) | 3.91651221 |
| 15 | detection of other organism (GO:0098543) | 3.85647956 |
| 16 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.82313690 |
| 17 | positive T cell selection (GO:0043368) | 3.79326062 |
| 18 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.72450643 |
| 19 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.70598454 |
| 20 | B cell receptor signaling pathway (GO:0050853) | 3.68682883 |
| 21 | thymic T cell selection (GO:0045061) | 3.66988788 |
| 22 | cellular response to interleukin-15 (GO:0071350) | 3.64284242 |
| 23 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.63043530 |
| 24 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.59083588 |
| 25 | T cell migration (GO:0072678) | 3.54524924 |
| 26 | neutrophil activation involved in immune response (GO:0002283) | 3.53423088 |
| 27 | T cell selection (GO:0045058) | 3.49547363 |
| 28 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.48135590 |
| 29 | positive regulation of granulocyte differentiation (GO:0030854) | 3.47532300 |
| 30 | negative regulation of T cell mediated immunity (GO:0002710) | 3.41123721 |
| 31 | regulation of leukocyte degranulation (GO:0043300) | 3.40104571 |
| 32 | negative regulation of innate immune response (GO:0045824) | 3.39483887 |
| 33 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.30040524 |
| 34 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.30040524 |
| 35 | tolerance induction (GO:0002507) | 3.29237044 |
| 36 | cellular extravasation (GO:0045123) | 3.20445231 |
| 37 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.15561250 |
| 38 | response to muramyl dipeptide (GO:0032495) | 3.13803990 |
| 39 | response to interferon-beta (GO:0035456) | 3.13642077 |
| 40 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.12773309 |
| 41 | energy homeostasis (GO:0097009) | 3.11147587 |
| 42 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.09713900 |
| 43 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.08654631 |
| 44 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.07080457 |
| 45 | myeloid cell activation involved in immune response (GO:0002275) | 3.04093431 |
| 46 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.03641693 |
| 47 | wound healing, spreading of epidermal cells (GO:0035313) | 3.01584003 |
| 48 | leukocyte degranulation (GO:0043299) | 2.99646176 |
| 49 | actin nucleation (GO:0045010) | 2.98882053 |
| 50 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.98680622 |
| 51 | respiratory burst (GO:0045730) | 2.98413883 |
| 52 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.96103019 |
| 53 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.96023266 |
| 54 | response to host immune response (GO:0052572) | 2.96023266 |
| 55 | macrophage activation involved in immune response (GO:0002281) | 2.92807689 |
| 56 | positive regulation of mast cell activation (GO:0033005) | 2.91541160 |
| 57 | positive regulation of macrophage differentiation (GO:0045651) | 2.91156983 |
| 58 | detection of external biotic stimulus (GO:0098581) | 2.90417742 |
| 59 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.89946049 |
| 60 | Peyers patch development (GO:0048541) | 2.87563952 |
| 61 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.87563952 |
| 62 | megakaryocyte development (GO:0035855) | 2.87295961 |
| 63 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.86524416 |
| 64 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.86524416 |
| 65 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.85115516 |
| 66 | mature B cell differentiation involved in immune response (GO:0002313) | 2.82685067 |
| 67 | regulation of interleukin-8 secretion (GO:2000482) | 2.82540882 |
| 68 | regulation of granulocyte differentiation (GO:0030852) | 2.81622941 |
| 69 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.80500676 |
| 70 | interferon-gamma production (GO:0032609) | 2.80029583 |
| 71 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.79862153 |
| 72 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.79086020 |
| 73 | negative regulation of interleukin-6 production (GO:0032715) | 2.78138619 |
| 74 | mast cell activation (GO:0045576) | 2.77715992 |
| 75 | chondrocyte proliferation (GO:0035988) | 2.75594205 |
| 76 | regulation of regulated secretory pathway (GO:1903305) | 2.74426225 |
| 77 | response to host (GO:0075136) | 2.72473925 |
| 78 | response to host defenses (GO:0052200) | 2.72473925 |
| 79 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.72473925 |
| 80 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.72149761 |
| 81 | response to peptidoglycan (GO:0032494) | 2.69876638 |
| 82 | regulation of necroptotic process (GO:0060544) | 2.68609370 |
| 83 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.64404849 |
| 84 | NIK/NF-kappaB signaling (GO:0038061) | 2.64233700 |
| 85 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.60291515 |
| 86 | wound healing, spreading of cells (GO:0044319) | 2.59342311 |
| 87 | immunoglobulin mediated immune response (GO:0016064) | 2.52919693 |
| 88 | cellular response to interferon-beta (GO:0035458) | 2.51898930 |
| 89 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.51069070 |
| 90 | phagocytosis, engulfment (GO:0006911) | 2.48168610 |
| 91 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.47783796 |
| 92 | negative regulation of mast cell activation (GO:0033004) | 2.46634454 |
| 93 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.43314520 |
| 94 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.41460952 |
| 95 | response to interferon-alpha (GO:0035455) | 2.40566829 |
| 96 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.37868708 |
| 97 | regulation of antigen processing and presentation (GO:0002577) | 2.37432589 |
| 98 | cellular response to type I interferon (GO:0071357) | 2.37407393 |
| 99 | type I interferon signaling pathway (GO:0060337) | 2.37407393 |
| 100 | angiogenesis involved in wound healing (GO:0060055) | 2.36346371 |
| 101 | response to type I interferon (GO:0034340) | 2.34934655 |
| 102 | fibril organization (GO:0097435) | 2.34697039 |
| 103 | regulation of T cell tolerance induction (GO:0002664) | 2.32379440 |
| 104 | mature B cell differentiation (GO:0002335) | 2.31382119 |
| 105 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.30331911 |
| 106 | neutrophil activation (GO:0042119) | 2.30048957 |
| 107 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.29197886 |
| 108 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.28672491 |
| 109 | ribosomal small subunit assembly (GO:0000028) | 2.27050379 |
| 110 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.26474943 |
| 111 | B cell mediated immunity (GO:0019724) | 2.25514498 |
| 112 | facial nerve structural organization (GO:0021612) | 2.22324983 |
| 113 | myeloid dendritic cell activation (GO:0001773) | 2.22268259 |
| 114 | negative regulation of phagocytosis (GO:0050765) | 2.21597412 |
| 115 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.20557749 |
| 116 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.20500155 |
| 117 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.20395454 |
| 118 | I-kappaB kinase/NF-kappaB signaling (GO:0007249) | 2.19840837 |
| 119 | response to protozoan (GO:0001562) | 2.19422558 |
| 120 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.18826918 |
| 121 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.18448127 |
| 122 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.17782470 |
| 123 | response to progesterone (GO:0032570) | 2.16700436 |
| 124 | phospholipid scrambling (GO:0017121) | 2.16634729 |
| 125 | hepatocyte apoptotic process (GO:0097284) | 2.13966227 |
| 126 | negative regulation of interleukin-12 production (GO:0032695) | 2.13509833 |
| 127 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.11513285 |
| 128 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.09125757 |
| 129 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.07881906 |
| 130 | membrane raft organization (GO:0031579) | 2.07881585 |
| 131 | regulation of mast cell activation (GO:0033003) | 2.07689524 |
| 132 | positive regulation by symbiont of host defense response (GO:0052509) | 2.07523706 |
| 133 | modulation by symbiont of host defense response (GO:0052031) | 2.07523706 |
| 134 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.07523706 |
| 135 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.07523706 |
| 136 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.07523706 |
| 137 | modulation by symbiont of host immune response (GO:0052553) | 2.07523706 |
| 138 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.06365536 |
| 139 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.05609783 |
| 140 | cellular defense response (GO:0006968) | 2.05404435 |
| 141 | regulation of RIG-I signaling pathway (GO:0039535) | 2.04706470 |
| 142 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.04017381 |
| 143 | positive regulation of hair cycle (GO:0042635) | 2.03615092 |
| 144 | positive regulation of hair follicle development (GO:0051798) | 2.03615092 |
| 145 | regulation of metalloenzyme activity (GO:0048552) | 2.03223486 |
| 146 | definitive hemopoiesis (GO:0060216) | 2.02669745 |
| 147 | regulation of cellular extravasation (GO:0002691) | 2.01622694 |
| 148 | regulation of macrophage differentiation (GO:0045649) | 2.01509124 |
| 149 | defense response to protozoan (GO:0042832) | 2.00731977 |
| 150 | cyclooxygenase pathway (GO:0019371) | 2.00489888 |
| 151 | regulation of T cell migration (GO:2000404) | 2.00174071 |
| 152 | sprouting angiogenesis (GO:0002040) | 2.00094332 |
| 153 | T cell apoptotic process (GO:0070231) | 1.99138685 |
| 154 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 1.98541169 |
| 155 | protein heterotetramerization (GO:0051290) | 1.97739119 |
| 156 | granulocyte activation (GO:0036230) | 1.96197630 |
| 157 | superoxide anion generation (GO:0042554) | 1.95215414 |
| 158 | regulation of tolerance induction (GO:0002643) | 1.95079750 |
| 159 | negative regulation of viral genome replication (GO:0045071) | 1.95003575 |
| 160 | substrate-dependent cell migration (GO:0006929) | 1.94898740 |
| 161 | positive regulation of antigen processing and presentation (GO:0002579) | 1.94522520 |
| 162 | positive regulation of monocyte chemotaxis (GO:0090026) | 1.94450426 |
| 163 | dendritic cell migration (GO:0036336) | 1.94104664 |
| 164 | regulation of vitamin metabolic process (GO:0030656) | 1.93892731 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.59332656 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.80122090 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.33509510 |
| 4 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.58146856 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.52099617 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.47661000 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.26006385 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.21604173 |
| 9 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.99350887 |
| 10 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.91617747 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.88981980 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.88234512 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.80938278 |
| 14 | * MYC_22102868_ChIP-Seq_BL_Human | 2.71810976 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.61480305 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.42675817 |
| 17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.33793056 |
| 18 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.27651044 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.26485242 |
| 20 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.25374272 |
| 21 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.23910313 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.23749243 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.22112697 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.22064713 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.20182426 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.16356485 |
| 27 | MAF_26560356_Chip-Seq_TH2_Human | 2.12818908 |
| 28 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.08884495 |
| 29 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.07408142 |
| 30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.06498095 |
| 31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.02878422 |
| 32 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.96962019 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.91668909 |
| 34 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.90832997 |
| 35 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.87667467 |
| 36 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.87021445 |
| 37 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.87021445 |
| 38 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.86129180 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.84641931 |
| 40 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.83462581 |
| 41 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.75117690 |
| 42 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73831736 |
| 43 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.73480615 |
| 44 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.73429726 |
| 45 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69157112 |
| 46 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.68619491 |
| 47 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.68115151 |
| 48 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67661040 |
| 49 | * MYB_26560356_Chip-Seq_TH2_Human | 1.64115441 |
| 50 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.59193517 |
| 51 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.57452309 |
| 52 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.56258711 |
| 53 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.53591700 |
| 54 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.53493864 |
| 55 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.53312119 |
| 56 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.51526103 |
| 57 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.49825031 |
| 58 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.48849347 |
| 59 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.48841487 |
| 60 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.48272734 |
| 61 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.47747933 |
| 62 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.47622479 |
| 63 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.47352636 |
| 64 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46035708 |
| 65 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.43999920 |
| 66 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43441397 |
| 67 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.40323920 |
| 68 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.40223669 |
| 69 | CJUN_26792858_Chip-Seq_BT549_Human | 1.39942447 |
| 70 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.39352541 |
| 71 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.37497974 |
| 72 | * MYB_26560356_Chip-Seq_TH1_Human | 1.37492041 |
| 73 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36002811 |
| 74 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.34504727 |
| 75 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.34092050 |
| 76 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.33672301 |
| 77 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.32076934 |
| 78 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.31859987 |
| 79 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31075472 |
| 80 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.30931611 |
| 81 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.29284771 |
| 82 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.28934555 |
| 83 | GATA1_19941826_ChIP-Seq_K562_Human | 1.27651722 |
| 84 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.27418069 |
| 85 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.26820915 |
| 86 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.26729943 |
| 87 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.24903031 |
| 88 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23476588 |
| 89 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.22510134 |
| 90 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22360608 |
| 91 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.22323548 |
| 92 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21587813 |
| 93 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.21440175 |
| 94 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.21013936 |
| 95 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20741588 |
| 96 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19419437 |
| 97 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.18344339 |
| 98 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.18283049 |
| 99 | P68_20966046_ChIP-Seq_HELA_Human | 1.17327507 |
| 100 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.16394659 |
| 101 | GATA3_26560356_Chip-Seq_TH2_Human | 1.15800411 |
| 102 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14539086 |
| 103 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13902786 |
| 104 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13472259 |
| 105 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.13049020 |
| 106 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.13038276 |
| 107 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.12374927 |
| 108 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.09756433 |
| 109 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09742419 |
| 110 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.07692844 |
| 111 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.07155744 |
| 112 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.07041619 |
| 113 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.05572888 |
| 114 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05294423 |
| 115 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.04872852 |
| 116 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04743694 |
| 117 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.03038715 |
| 118 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02466618 |
| 119 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.02336100 |
| 120 | * MAF_26560356_Chip-Seq_TH1_Human | 1.01538446 |
| 121 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01412893 |
| 122 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.00301472 |
| 123 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.00019253 |
| 124 | P300_27268052_Chip-Seq_Bcells_Human | 0.98097225 |
| 125 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.97974744 |
| 126 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96451819 |
| 127 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95821409 |
| 128 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.95362042 |
| 129 | GATA1_22025678_ChIP-Seq_K562_Human | 0.93825854 |
| 130 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93804245 |
| 131 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93168372 |
| 132 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.93072952 |
| 133 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.92897892 |
| 134 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.92682779 |
| 135 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.92398132 |
| 136 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.92054860 |
| 137 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91835191 |
| 138 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.91796628 |
| 139 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.90164526 |
| 140 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.89440189 |
| 141 | UTX_26944678_Chip-Seq_JUKART_Human | 0.89142162 |
| 142 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.88830117 |
| 143 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.88762470 |
| 144 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.88014946 |
| 145 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.87138210 |
| 146 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.86870146 |
| 147 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.86738657 |
| 148 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85204604 |
| 149 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.84398002 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 3.35719748 |
| 2 | MP0001835_abnormal_antigen_presentation | 2.50842474 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 2.46092800 |
| 4 | MP0003303_peritoneal_inflammation | 2.37771783 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 2.24473640 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 2.20456320 |
| 7 | MP0009785_altered_susceptibility_to | 2.18469291 |
| 8 | MP0003436_decreased_susceptibility_to | 2.16928915 |
| 9 | MP0003941_abnormal_skin_development | 2.11073469 |
| 10 | MP0002396_abnormal_hematopoietic_system | 2.07253934 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.00738432 |
| 12 | MP0002009_preneoplasia | 1.95909035 |
| 13 | MP0003279_aneurysm | 1.90321345 |
| 14 | MP0005000_abnormal_immune_tolerance | 1.89853771 |
| 15 | MP0002166_altered_tumor_susceptibility | 1.79997923 |
| 16 | MP0003566_abnormal_cell_adhesion | 1.78505947 |
| 17 | MP0000685_abnormal_immune_system | 1.78265307 |
| 18 | MP0002006_tumorigenesis | 1.76561859 |
| 19 | MP0003763_abnormal_thymus_physiology | 1.75357823 |
| 20 | MP0005275_abnormal_skin_tensile | 1.74794347 |
| 21 | MP0002419_abnormal_innate_immunity | 1.74760368 |
| 22 | MP0005257_abnormal_intraocular_pressure | 1.74605239 |
| 23 | MP0001533_abnormal_skeleton_physiology | 1.73263525 |
| 24 | MP0005025_abnormal_response_to | 1.72544323 |
| 25 | MP0005058_abnormal_lysosome_morphology | 1.70032004 |
| 26 | MP0003828_pulmonary_edema | 1.68125415 |
| 27 | MP0001853_heart_inflammation | 1.66300081 |
| 28 | MP0000858_altered_metastatic_potential | 1.65967092 |
| 29 | MP0002452_abnormal_antigen_presenting | 1.63875668 |
| 30 | MP0002405_respiratory_system_inflammati | 1.62226692 |
| 31 | MP0003950_abnormal_plasma_membrane | 1.59116308 |
| 32 | MP0003448_altered_tumor_morphology | 1.57065911 |
| 33 | MP0004808_abnormal_hematopoietic_stem | 1.56040156 |
| 34 | MP0002132_abnormal_respiratory_system | 1.54282904 |
| 35 | MP0008007_abnormal_cellular_replicative | 1.54189971 |
| 36 | MP0005503_abnormal_tendon_morphology | 1.53881044 |
| 37 | MP0005387_immune_system_phenotype | 1.53806011 |
| 38 | MP0001790_abnormal_immune_system | 1.53806011 |
| 39 | MP0002060_abnormal_skin_morphology | 1.53566142 |
| 40 | MP0002723_abnormal_immune_serum | 1.52149732 |
| 41 | MP0002420_abnormal_adaptive_immunity | 1.51569365 |
| 42 | MP0001819_abnormal_immune_cell | 1.51199979 |
| 43 | MP0005671_abnormal_response_to | 1.49745385 |
| 44 | MP0003656_abnormal_erythrocyte_physiolo | 1.49413245 |
| 45 | MP0001800_abnormal_humoral_immune | 1.48511144 |
| 46 | MP0001879_abnormal_lymphatic_vessel | 1.48268700 |
| 47 | MP0002933_joint_inflammation | 1.47039488 |
| 48 | MP0005023_abnormal_wound_healing | 1.43461170 |
| 49 | MP0006054_spinal_hemorrhage | 1.43333777 |
| 50 | MP0008469_abnormal_protein_level | 1.42383137 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 1.41521529 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.41521529 |
| 53 | MP0003091_abnormal_cell_migration | 1.41252349 |
| 54 | MP0005390_skeleton_phenotype | 1.39631092 |
| 55 | MP0005075_abnormal_melanosome_morpholog | 1.37935135 |
| 56 | MP0008260_abnormal_autophagy | 1.36989670 |
| 57 | MP0010368_abnormal_lymphatic_system | 1.33406346 |
| 58 | MP0009333_abnormal_splenocyte_physiolog | 1.29729144 |
| 59 | MP0000465_gastrointestinal_hemorrhage | 1.28081797 |
| 60 | MP0002877_abnormal_melanocyte_morpholog | 1.27636258 |
| 61 | MP0010155_abnormal_intestine_physiology | 1.27490589 |
| 62 | MP0004947_skin_inflammation | 1.26446536 |
| 63 | MP0004272_abnormal_basement_membrane | 1.26083473 |
| 64 | MP0001986_abnormal_taste_sensitivity | 1.24969890 |
| 65 | MP0001542_abnormal_bone_strength | 1.22900167 |
| 66 | MP0000490_abnormal_crypts_of | 1.20280887 |
| 67 | MP0001243_abnormal_dermal_layer | 1.20173026 |
| 68 | MP0002398_abnormal_bone_marrow | 1.19964176 |
| 69 | MP0003806_abnormal_nucleotide_metabolis | 1.19544654 |
| 70 | MP0000343_altered_response_to | 1.18311234 |
| 71 | MP0002163_abnormal_gland_morphology | 1.17498739 |
| 72 | MP0000767_abnormal_smooth_muscle | 1.16911690 |
| 73 | MP0004510_myositis | 1.16671710 |
| 74 | MP0010352_gastrointestinal_tract_polyps | 1.16087931 |
| 75 | MP0001958_emphysema | 1.15597216 |
| 76 | MP0008057_abnormal_DNA_replication | 1.14868251 |
| 77 | MP0001851_eye_inflammation | 1.13563783 |
| 78 | MP0000716_abnormal_immune_system | 1.11824491 |
| 79 | MP0005164_abnormal_response_to | 1.09931022 |
| 80 | MP0002998_abnormal_bone_remodeling | 1.09722501 |
| 81 | MP0000015_abnormal_ear_pigmentation | 1.09493756 |
| 82 | MP0005451_abnormal_body_composition | 1.08306578 |
| 83 | MP0005310_abnormal_salivary_gland | 1.07316846 |
| 84 | MP0002722_abnormal_immune_system | 1.05770428 |
| 85 | MP0009278_abnormal_bone_marrow | 1.05555763 |
| 86 | MP0005508_abnormal_skeleton_morphology | 1.03552715 |
| 87 | MP0003693_abnormal_embryo_hatching | 1.02906437 |
| 88 | MP0001873_stomach_inflammation | 1.02812657 |
| 89 | MP0000689_abnormal_spleen_morphology | 1.01252782 |
| 90 | MP0001845_abnormal_inflammatory_respons | 1.01004826 |
| 91 | MP0001216_abnormal_epidermal_layer | 0.96967187 |
| 92 | MP0002429_abnormal_blood_cell | 0.96644450 |
| 93 | * MP0009763_increased_sensitivity_to | 0.96216951 |
| 94 | MP0005464_abnormal_platelet_physiology | 0.95737993 |
| 95 | * MP0002019_abnormal_tumor_incidence | 0.95027232 |
| 96 | MP0004381_abnormal_hair_follicle | 0.94124724 |
| 97 | MP0004782_abnormal_surfactant_physiolog | 0.93191965 |
| 98 | MP0000372_irregular_coat_pigmentation | 0.92941728 |
| 99 | MP0000703_abnormal_thymus_morphology | 0.92859250 |
| 100 | MP0009840_abnormal_foam_cell | 0.92456879 |
| 101 | MP0003075_altered_response_to | 0.89543139 |
| 102 | MP0003183_abnormal_peptide_metabolism | 0.86047296 |
| 103 | MP0002098_abnormal_vibrissa_morphology | 0.86011912 |
| 104 | MP0003795_abnormal_bone_structure | 0.85380200 |
| 105 | MP0003453_abnormal_keratinocyte_physiol | 0.83776510 |
| 106 | MP0000604_amyloidosis | 0.83263449 |
| 107 | MP0009379_abnormal_foot_pigmentation | 0.82726481 |
| 108 | MP0009250_abnormal_appendicular_skeleto | 0.81443343 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.79277745 |
| 110 | MP0002295_abnormal_pulmonary_circulatio | 0.79223251 |
| 111 | MP0004883_abnormal_blood_vessel | 0.78819283 |
| 112 | MP0003300_gastrointestinal_ulcer | 0.78694125 |
| 113 | MP0008004_abnormal_stomach_pH | 0.78366936 |
| 114 | MP0000249_abnormal_blood_vessel | 0.78194445 |
| 115 | MP0001188_hyperpigmentation | 0.77793356 |
| 116 | MP0006082_CNS_inflammation | 0.76651666 |
| 117 | MP0003866_abnormal_defecation | 0.75624300 |
| 118 | MP0003943_abnormal_hepatobiliary_system | 0.75491638 |
| 119 | MP0009764_decreased_sensitivity_to | 0.74321573 |
| 120 | MP0009384_cardiac_valve_regurgitation | 0.73151818 |
| 121 | MP0001663_abnormal_digestive_system | 0.67275455 |
| 122 | * MP0005166_decreased_susceptibility_to | 0.57172530 |
| 123 | MP0006036_abnormal_mitochondrial_physio | 0.55607826 |
| 124 | MP0003786_premature_aging | 0.55310241 |
| 125 | MP0002138_abnormal_hepatobiliary_system | 0.54812594 |
| 126 | MP0005319_abnormal_enzyme/_coenzyme | 0.53155348 |
| 127 | MP0008874_decreased_physiological_sensi | 0.52552941 |
| 128 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.50619901 |
| 129 | MP0003045_fibrosis | 0.49350428 |
| 130 | MP0009931_abnormal_skin_appearance | 0.49041145 |
| 131 | MP0000681_abnormal_thyroid_gland | 0.45402878 |
| 132 | MP0005083_abnormal_biliary_tract | 0.45258809 |
| 133 | * MP0008873_increased_physiological_sensi | 0.44936812 |
| 134 | MP0000609_abnormal_liver_physiology | 0.43401066 |
| 135 | MP0005174_abnormal_tail_pigmentation | 0.42565545 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Panhypogammaglobulinemia (HP:0003139) | 4.30206577 |
| 2 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.21456499 |
| 3 | Prostate neoplasm (HP:0100787) | 4.10421516 |
| 4 | Premature rupture of membranes (HP:0001788) | 3.80173067 |
| 5 | Meningitis (HP:0001287) | 3.79689535 |
| 6 | Prolonged bleeding time (HP:0003010) | 3.65964339 |
| 7 | Myositis (HP:0100614) | 3.61088177 |
| 8 | T lymphocytopenia (HP:0005403) | 3.58851682 |
| 9 | Recurrent cutaneous fungal infections (HP:0011370) | 3.52979196 |
| 10 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.52979196 |
| 11 | Agammaglobulinemia (HP:0004432) | 3.46461219 |
| 12 | Encephalitis (HP:0002383) | 3.45872560 |
| 13 | Abnormality of T cells (HP:0002843) | 3.41737660 |
| 14 | Abnormality of T cell number (HP:0011839) | 3.41559787 |
| 15 | Gastrointestinal infarctions (HP:0005244) | 3.38900155 |
| 16 | Recurrent skin infections (HP:0001581) | 3.28426006 |
| 17 | Epistaxis (HP:0000421) | 3.20517323 |
| 18 | Recurrent abscess formation (HP:0002722) | 3.16484441 |
| 19 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.14012501 |
| 20 | Increased IgE level (HP:0003212) | 3.13440984 |
| 21 | Orchitis (HP:0100796) | 3.13300687 |
| 22 | Autoimmune hemolytic anemia (HP:0001890) | 3.12678187 |
| 23 | Eczematoid dermatitis (HP:0000976) | 3.08176622 |
| 24 | Chest pain (HP:0100749) | 3.08174230 |
| 25 | Severe combined immunodeficiency (HP:0004430) | 3.05795733 |
| 26 | Inflammation of the large intestine (HP:0002037) | 3.03312884 |
| 27 | Gastrointestinal inflammation (HP:0004386) | 3.03268606 |
| 28 | Abnormality of T cell physiology (HP:0011840) | 2.99752273 |
| 29 | Optic neuritis (HP:0100653) | 2.99221712 |
| 30 | Retrobulbar optic neuritis (HP:0100654) | 2.99221712 |
| 31 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.94295773 |
| 32 | Spontaneous hematomas (HP:0007420) | 2.94102389 |
| 33 | Syringomyelia (HP:0003396) | 2.89992293 |
| 34 | Spinal cord lesions (HP:0100561) | 2.89992293 |
| 35 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.85086189 |
| 36 | Urticaria (HP:0001025) | 2.80068672 |
| 37 | Protrusio acetabuli (HP:0003179) | 2.78586775 |
| 38 | Atrophic scars (HP:0001075) | 2.74669118 |
| 39 | Colitis (HP:0002583) | 2.68545256 |
| 40 | Abnormality of the prostate (HP:0008775) | 2.59618852 |
| 41 | Recurrent bacterial skin infections (HP:0005406) | 2.58203169 |
| 42 | Upper limb muscle weakness (HP:0003484) | 2.54052748 |
| 43 | Aortic dissection (HP:0002647) | 2.50553097 |
| 44 | Gingival bleeding (HP:0000225) | 2.49947605 |
| 45 | Distal lower limb muscle weakness (HP:0009053) | 2.49812084 |
| 46 | Vertebral compression fractures (HP:0002953) | 2.49426162 |
| 47 | Cervical subluxation (HP:0003308) | 2.48175835 |
| 48 | Stomatitis (HP:0010280) | 2.47437904 |
| 49 | Hemoptysis (HP:0002105) | 2.46837534 |
| 50 | Hypochromic anemia (HP:0001931) | 2.46643644 |
| 51 | Increased serum ferritin (HP:0003281) | 2.43775902 |
| 52 | Hepatosplenomegaly (HP:0001433) | 2.43461944 |
| 53 | IgG deficiency (HP:0004315) | 2.43100696 |
| 54 | Gingivitis (HP:0000230) | 2.42753122 |
| 55 | Combined immunodeficiency (HP:0005387) | 2.40349450 |
| 56 | Pulmonary artery stenosis (HP:0004415) | 2.32357329 |
| 57 | Lymphopenia (HP:0001888) | 2.31323274 |
| 58 | Arterial thrombosis (HP:0004420) | 2.30248761 |
| 59 | Episodic fever (HP:0001954) | 2.30072155 |
| 60 | Recurrent bronchitis (HP:0002837) | 2.29962434 |
| 61 | Dysostosis multiplex (HP:0000943) | 2.28175426 |
| 62 | Soft skin (HP:0000977) | 2.27417751 |
| 63 | Abnormality of iron homeostasis (HP:0011031) | 2.26385547 |
| 64 | Stomach cancer (HP:0012126) | 2.25610880 |
| 65 | Purpura (HP:0000979) | 2.25131881 |
| 66 | Petechiae (HP:0000967) | 2.24455640 |
| 67 | Increased cerebral lipofuscin (HP:0011813) | 2.22117872 |
| 68 | Osteolytic defects of the hand bones (HP:0009699) | 2.19839389 |
| 69 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.19839389 |
| 70 | Acute hepatic failure (HP:0006554) | 2.19450479 |
| 71 | Hypertensive crisis (HP:0100735) | 2.19016983 |
| 72 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.18605589 |
| 73 | Verrucae (HP:0200043) | 2.18113628 |
| 74 | Papilloma (HP:0012740) | 2.18113628 |
| 75 | Hypochromic microcytic anemia (HP:0004840) | 2.14641429 |
| 76 | Granulocytopenia (HP:0001913) | 2.14428431 |
| 77 | Aplastic anemia (HP:0001915) | 2.13678735 |
| 78 | Abnormality of glycolipid metabolism (HP:0010969) | 2.13142685 |
| 79 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.13142685 |
| 80 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.13142685 |
| 81 | Anhidrosis (HP:0000970) | 2.12597015 |
| 82 | Mediastinal lymphadenopathy (HP:0100721) | 2.12380126 |
| 83 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.12062154 |
| 84 | Sepsis (HP:0100806) | 2.11801948 |
| 85 | Pulmonary infiltrates (HP:0002113) | 2.10707238 |
| 86 | Eosinophilia (HP:0001880) | 2.09923809 |
| 87 | Vacuolated lymphocytes (HP:0001922) | 2.09297943 |
| 88 | Abnormality of the pleura (HP:0002103) | 2.07665722 |
| 89 | Skin rash (HP:0000988) | 2.03943143 |
| 90 | Pulmonary embolism (HP:0002204) | 2.03934671 |
| 91 | Microcytic anemia (HP:0001935) | 2.02886464 |
| 92 | Mesomelia (HP:0003027) | 2.01348345 |
| 93 | Chronic diarrhea (HP:0002028) | 2.00657841 |
| 94 | Anorexia (HP:0002039) | 1.99556244 |
| 95 | Short nail (HP:0001799) | 1.96350330 |
| 96 | Patchy hypopigmentation of hair (HP:0011365) | 1.94650891 |
| 97 | Congenital, generalized hypertrichosis (HP:0004540) | 1.93778856 |
| 98 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.93446943 |
| 99 | Recurrent fungal infections (HP:0002841) | 1.93001329 |
| 100 | Thrombocytosis (HP:0001894) | 1.92602429 |
| 101 | Peritonitis (HP:0002586) | 1.91965761 |
| 102 | Hypoproteinemia (HP:0003075) | 1.91304087 |
| 103 | Glomerulopathy (HP:0100820) | 1.91136955 |
| 104 | Abnormal platelet function (HP:0011869) | 1.90789162 |
| 105 | Impaired platelet aggregation (HP:0003540) | 1.90789162 |
| 106 | Autoimmune thrombocytopenia (HP:0001973) | 1.90574820 |
| 107 | Leukocytosis (HP:0001974) | 1.90385242 |
| 108 | Increased density of long bones (HP:0006392) | 1.90180928 |
| 109 | Spinal rigidity (HP:0003306) | 1.90159890 |
| 110 | Chronic otitis media (HP:0000389) | 1.89927227 |
| 111 | Wormian bones (HP:0002645) | 1.89311104 |
| 112 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.89305313 |
| 113 | Abnormality of dentin (HP:0010299) | 1.88728512 |
| 114 | Recurrent viral infections (HP:0004429) | 1.87512469 |
| 115 | Keratoconjunctivitis sicca (HP:0001097) | 1.86110538 |
| 116 | Aortic aneurysm (HP:0004942) | 1.85183914 |
| 117 | Abnormality of macrophages (HP:0004311) | 1.82607015 |
| 118 | Vasculitis (HP:0002633) | 1.81760621 |
| 119 | Muscle fiber atrophy (HP:0100295) | 1.80548506 |
| 120 | Chromsome breakage (HP:0040012) | 1.80135539 |
| 121 | Increased connective tissue (HP:0009025) | 1.79996320 |
| 122 | White forelock (HP:0002211) | 1.79694031 |
| 123 | Reticulocytopenia (HP:0001896) | 1.77134698 |
| 124 | Increased IgM level (HP:0003496) | 1.76529987 |
| 125 | Abnormality of eosinophils (HP:0001879) | 1.76137538 |
| 126 | Abnormality of the renal collecting system (HP:0004742) | 1.76021068 |
| 127 | Absent frontal sinuses (HP:0002688) | 1.75918008 |
| 128 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.73572556 |
| 129 | Biconcave vertebral bodies (HP:0004586) | 1.73570005 |
| 130 | Osteomyelitis (HP:0002754) | 1.72308420 |
| 131 | Fragile skin (HP:0001030) | 1.70749043 |
| 132 | Chronic obstructive pulmonary disease (HP:0006510) | 1.70111329 |
| 133 | Obstructive lung disease (HP:0006536) | 1.70111329 |
| 134 | 11 pairs of ribs (HP:0000878) | 1.70052426 |
| 135 | Aplasia cutis congenita (HP:0001057) | 1.69901302 |
| 136 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.69761870 |
| 137 | B lymphocytopenia (HP:0010976) | 1.69225075 |
| 138 | Abnormality of B cell number (HP:0010975) | 1.69225075 |
| 139 | Xerostomia (HP:0000217) | 1.68018954 |
| 140 | IgM deficiency (HP:0002850) | 1.66803672 |
| 141 | Hypergammaglobulinemia (HP:0010702) | 1.66701384 |
| 142 | Submucous cleft hard palate (HP:0000176) | 1.66364016 |
| 143 | Lip pit (HP:0100267) | 1.66076909 |
| 144 | Distal lower limb amyotrophy (HP:0008944) | 1.65337483 |
| 145 | Recurrent pneumonia (HP:0006532) | 1.64594487 |
| 146 | Conical tooth (HP:0000698) | 1.63911315 |
| 147 | Keratoconjunctivitis (HP:0001096) | 1.63288684 |
| 148 | Thick nail (HP:0001805) | 1.63093677 |
| 149 | Skin ulcer (HP:0200042) | 1.62892102 |
| 150 | Neonatal short-limb short stature (HP:0008921) | 1.60550027 |
| 151 | Dilatation of the ascending aorta (HP:0005111) | 1.60396401 |
| 152 | Abnormality of the nasal mucosa (HP:0000433) | 1.58660362 |
| 153 | Natal tooth (HP:0000695) | 1.58579167 |
| 154 | Cellulitis (HP:0100658) | 1.57797049 |
| 155 | Right ventricular cardiomyopathy (HP:0011663) | 1.55935516 |
| 156 | Rough bone trabeculation (HP:0100670) | 1.53407257 |
| 157 | Pustule (HP:0200039) | 1.53249354 |
| 158 | Abnormality of the acetabulum (HP:0003170) | 1.53144310 |
| 159 | Short middle phalanx of the 5th finger (HP:0004220) | 1.52803824 |
| 160 | Aortic valve stenosis (HP:0001650) | 1.51984280 |
| 161 | Joint stiffness (HP:0001387) | 1.51004607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.32932314 |
| 2 | MAP3K14 | 3.23246801 |
| 3 | PIM2 | 3.23216609 |
| 4 | FES | 3.16241227 |
| 5 | GRK6 | 2.93024833 |
| 6 | ERN1 | 2.80123132 |
| 7 | TAOK3 | 2.60807157 |
| 8 | MAP3K3 | 2.41672960 |
| 9 | ZAK | 2.33867013 |
| 10 | PRPF4B | 2.27243684 |
| 11 | MST1R | 2.23829047 |
| 12 | IRAK4 | 2.20119911 |
| 13 | BMPR1B | 2.11551804 |
| 14 | TESK2 | 2.08212778 |
| 15 | EPHA2 | 2.05971281 |
| 16 | TNK2 | 2.05567442 |
| 17 | TIE1 | 1.96985157 |
| 18 | TBK1 | 1.95686315 |
| 19 | TRPM7 | 1.95411343 |
| 20 | TEC | 1.92793297 |
| 21 | PIK3CA | 1.92698395 |
| 22 | RPS6KA4 | 1.91178457 |
| 23 | MAP3K13 | 1.85886942 |
| 24 | IKBKB | 1.85161975 |
| 25 | STK16 | 1.79869755 |
| 26 | TGFBR2 | 1.79532566 |
| 27 | KDR | 1.79011504 |
| 28 | IKBKE | 1.72540037 |
| 29 | MAP2K3 | 1.71401517 |
| 30 | TGFBR1 | 1.68559250 |
| 31 | NME2 | 1.65492471 |
| 32 | TXK | 1.65048886 |
| 33 | EPHA3 | 1.55908904 |
| 34 | BLK | 1.51588125 |
| 35 | KIT | 1.49050988 |
| 36 | TYK2 | 1.48412026 |
| 37 | MST4 | 1.46815198 |
| 38 | MAP4K1 | 1.43694070 |
| 39 | JAK3 | 1.43218842 |
| 40 | BTK | 1.34227734 |
| 41 | CHUK | 1.32081046 |
| 42 | MYLK | 1.29547590 |
| 43 | TESK1 | 1.26253158 |
| 44 | TTN | 1.24149082 |
| 45 | IRAK3 | 1.22671776 |
| 46 | CLK1 | 1.21517300 |
| 47 | PIM1 | 1.20766886 |
| 48 | BUB1 | 1.20678894 |
| 49 | ERBB3 | 1.17174594 |
| 50 | TAOK2 | 1.14535456 |
| 51 | BCKDK | 1.13724127 |
| 52 | NUAK1 | 1.12839674 |
| 53 | EIF2AK2 | 1.12730452 |
| 54 | PIK3CG | 1.09399466 |
| 55 | NEK9 | 1.08897215 |
| 56 | STK10 | 1.07134587 |
| 57 | VRK1 | 0.97537795 |
| 58 | JAK2 | 0.97453987 |
| 59 | RIPK1 | 0.96131334 |
| 60 | ITK | 0.94365219 |
| 61 | SIK2 | 0.94128360 |
| 62 | BCR | 0.92015399 |
| 63 | MARK3 | 0.91262358 |
| 64 | MAP2K2 | 0.91178564 |
| 65 | RPS6KB2 | 0.91077007 |
| 66 | MAPKAPK5 | 0.90202127 |
| 67 | PBK | 0.86756024 |
| 68 | MATK | 0.83726319 |
| 69 | PRKD2 | 0.83120405 |
| 70 | TRIB3 | 0.81516264 |
| 71 | PRKCQ | 0.79949472 |
| 72 | ZAP70 | 0.79493732 |
| 73 | MKNK1 | 0.78870164 |
| 74 | LCK | 0.76843130 |
| 75 | MAP3K1 | 0.76544027 |
| 76 | GRK7 | 0.76450095 |
| 77 | MAPKAPK3 | 0.74824224 |
| 78 | TSSK6 | 0.73790650 |
| 79 | MAPK12 | 0.73569577 |
| 80 | TAOK1 | 0.73067954 |
| 81 | BMPR2 | 0.72571039 |
| 82 | MAPK7 | 0.72360054 |
| 83 | EPHB2 | 0.71700153 |
| 84 | FGR | 0.69757417 |
| 85 | RPS6KA5 | 0.69169384 |
| 86 | DYRK3 | 0.68944406 |
| 87 | NLK | 0.66401858 |
| 88 | SIK3 | 0.66361223 |
| 89 | HIPK2 | 0.65125232 |
| 90 | HCK | 0.64977951 |
| 91 | PDK1 | 0.64798536 |
| 92 | MAP3K6 | 0.64657499 |
| 93 | MAPKAPK2 | 0.63841265 |
| 94 | RAF1 | 0.63746595 |
| 95 | FLT3 | 0.63406706 |
| 96 | MAPK11 | 0.62930458 |
| 97 | MAP3K7 | 0.62905112 |
| 98 | LYN | 0.62749574 |
| 99 | CDK8 | 0.61425936 |
| 100 | CDK3 | 0.61313655 |
| 101 | STK24 | 0.60849357 |
| 102 | SMG1 | 0.59423982 |
| 103 | MARK2 | 0.58352396 |
| 104 | JAK1 | 0.58186714 |
| 105 | MET | 0.56604626 |
| 106 | CSK | 0.56301715 |
| 107 | SYK | 0.55728493 |
| 108 | SCYL2 | 0.55029556 |
| 109 | LRRK2 | 0.54672566 |
| 110 | PTK2B | 0.52755577 |
| 111 | DMPK | 0.52659637 |
| 112 | STK4 | 0.52650945 |
| 113 | RPS6KL1 | 0.52153419 |
| 114 | RPS6KC1 | 0.52153419 |
| 115 | MAP3K11 | 0.51638231 |
| 116 | STK38L | 0.50569185 |
| 117 | CDK9 | 0.49464895 |
| 118 | BRD4 | 0.49026855 |
| 119 | DYRK1B | 0.48151534 |
| 120 | MKNK2 | 0.47921382 |
| 121 | GRK1 | 0.47612886 |
| 122 | MAP4K2 | 0.46746933 |
| 123 | CDC42BPA | 0.46236265 |
| 124 | CDK6 | 0.46210126 |
| 125 | TLK1 | 0.45423939 |
| 126 | NME1 | 0.44748519 |
| 127 | PDPK1 | 0.44742978 |
| 128 | YES1 | 0.44425978 |
| 129 | CDK7 | 0.44240875 |
| 130 | FER | 0.43881848 |
| 131 | EIF2AK3 | 0.43775455 |
| 132 | MOS | 0.43772761 |
| 133 | MAPK4 | 0.43688070 |
| 134 | CSF1R | 0.42948545 |
| 135 | FYN | 0.42875185 |
| 136 | IRAK2 | 0.42815411 |
| 137 | ACVR1B | 0.41039954 |
| 138 | ABL1 | 0.40815114 |
| 139 | MAP3K8 | 0.39630243 |
| 140 | ADRBK2 | 0.39394929 |
| 141 | MAP2K6 | 0.39165077 |
| 142 | MAPK15 | 0.39160332 |
| 143 | MAPK3 | 0.38886407 |
| 144 | MAP2K1 | 0.38193505 |
| 145 | RPS6KA6 | 0.37733882 |
| 146 | EPHB1 | 0.37230938 |
| 147 | IRAK1 | 0.37020287 |
| 148 | PTK6 | 0.36876827 |
| 149 | CDK19 | 0.36180668 |
| 150 | MAP3K5 | 0.35316540 |
| 151 | CAMKK2 | 0.32958856 |
| 152 | PRKD1 | 0.30988332 |
| 153 | RPS6KA2 | 0.27173136 |
| 154 | BMX | 0.26330907 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.30196514 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.23124940 |
| 3 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.22592341 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.06748401 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.97192861 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.92172797 |
| 7 | Measles_Homo sapiens_hsa05162 | 1.83891697 |
| 8 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.71308243 |
| 9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.69343601 |
| 10 | Malaria_Homo sapiens_hsa05144 | 1.65152902 |
| 11 | Shigellosis_Homo sapiens_hsa05131 | 1.64840981 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.60408597 |
| 13 | Proteasome_Homo sapiens_hsa03050 | 1.60034299 |
| 14 | Ribosome_Homo sapiens_hsa03010 | 1.59289428 |
| 15 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.58221402 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.58085693 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.55751194 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.52814863 |
| 19 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.51630200 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.48619018 |
| 21 | Pertussis_Homo sapiens_hsa05133 | 1.47155411 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.46536333 |
| 23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.45388799 |
| 24 | Legionellosis_Homo sapiens_hsa05134 | 1.45269695 |
| 25 | Allograft rejection_Homo sapiens_hsa05330 | 1.44792884 |
| 26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.35642846 |
| 27 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.35463719 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.33862153 |
| 29 | DNA replication_Homo sapiens_hsa03030 | 1.32974418 |
| 30 | Apoptosis_Homo sapiens_hsa04210 | 1.31424991 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.31159466 |
| 32 | Homologous recombination_Homo sapiens_hsa03440 | 1.29562622 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.28974365 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.26305059 |
| 35 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.22061920 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.20126120 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.18080570 |
| 38 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.16777247 |
| 39 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.16516523 |
| 40 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.13302286 |
| 41 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.12400646 |
| 42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.12084047 |
| 43 | Protein export_Homo sapiens_hsa03060 | 1.09636237 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.08760726 |
| 45 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.07860498 |
| 46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05715673 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.01936827 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.01484175 |
| 49 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.01098132 |
| 50 | Lysosome_Homo sapiens_hsa04142 | 0.99726666 |
| 51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.99425842 |
| 52 | HTLV-I infection_Homo sapiens_hsa05166 | 0.98643540 |
| 53 | Other glycan degradation_Homo sapiens_hsa00511 | 0.96713615 |
| 54 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.96455525 |
| 55 | RNA polymerase_Homo sapiens_hsa03020 | 0.96154194 |
| 56 | Phagosome_Homo sapiens_hsa04145 | 0.96045564 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.94740729 |
| 58 | RNA degradation_Homo sapiens_hsa03018 | 0.94390695 |
| 59 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.94316757 |
| 60 | Base excision repair_Homo sapiens_hsa03410 | 0.93767320 |
| 61 | Asthma_Homo sapiens_hsa05310 | 0.92861515 |
| 62 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.92364954 |
| 63 | Focal adhesion_Homo sapiens_hsa04510 | 0.92276841 |
| 64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.92243728 |
| 65 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.91089494 |
| 66 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.91051766 |
| 67 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.90355935 |
| 68 | Mismatch repair_Homo sapiens_hsa03430 | 0.89074824 |
| 69 | Adherens junction_Homo sapiens_hsa04520 | 0.88709009 |
| 70 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.88061878 |
| 71 | Cell cycle_Homo sapiens_hsa04110 | 0.87106711 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 0.86082362 |
| 73 | Tuberculosis_Homo sapiens_hsa05152 | 0.85779287 |
| 74 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.79404128 |
| 75 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.79402364 |
| 76 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.77244953 |
| 77 | * Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.76564472 |
| 78 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.76095020 |
| 79 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.75725282 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75298410 |
| 81 | Viral myocarditis_Homo sapiens_hsa05416 | 0.75002996 |
| 82 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.74471498 |
| 83 | Platelet activation_Homo sapiens_hsa04611 | 0.73963985 |
| 84 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.70686882 |
| 85 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.70387969 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.69747461 |
| 87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.69702883 |
| 88 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.68977448 |
| 89 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68428225 |
| 90 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.68111584 |
| 91 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.67792722 |
| 92 | * Bladder cancer_Homo sapiens_hsa05219 | 0.66088494 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65571742 |
| 94 | Spliceosome_Homo sapiens_hsa03040 | 0.65298077 |
| 95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.64934301 |
| 96 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.62937372 |
| 97 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61743600 |
| 98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60933921 |
| 99 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.59197164 |
| 100 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59138248 |
| 101 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.59053709 |
| 102 | Prostate cancer_Homo sapiens_hsa05215 | 0.58460568 |
| 103 | Amoebiasis_Homo sapiens_hsa05146 | 0.58273348 |
| 104 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.57731200 |
| 105 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57061968 |
| 106 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.56103203 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55947059 |
| 108 | Basal transcription factors_Homo sapiens_hsa03022 | 0.55621011 |
| 109 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.54821447 |
| 110 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52829314 |
| 111 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.52353974 |
| 112 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.51150001 |
| 113 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50855516 |
| 114 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.50731673 |
| 115 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50658614 |
| 116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50544125 |
| 117 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.50492369 |
| 118 | Melanoma_Homo sapiens_hsa05218 | 0.48274123 |
| 119 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44877542 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44009283 |
| 121 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.35749146 |
| 122 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.35048705 |
| 123 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.34590288 |
| 124 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.34548413 |
| 125 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.33657603 |
| 126 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.33240803 |
| 127 | Colorectal cancer_Homo sapiens_hsa05210 | 0.33060417 |
| 128 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.30087645 |
| 129 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.29782627 |
| 130 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.29432378 |
| 131 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27396528 |
| 132 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.26643364 |
| 133 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.26205766 |
| 134 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.23610752 |
| 135 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.21599008 |
| 136 | Insulin resistance_Homo sapiens_hsa04931 | 0.18581113 |

